Statistically, TRPV3 expression is decreased in colorectal cancer, and it is increased in pancreatic cancer, bone cancer, breast cancer, lung cancer and oral squamous cell carcinoma [21,50,52,70]. Here, TRPV3 is linked to bone cancer.